Global

Toxicology Experts

Ravi P Sahu

Ph.D.
Department of PHARMACOLOGY & TOXICOLOGY
Wright State University
United States of America

Biography

EDUCATION B.S.: University of Allahabad, Allahabad, India M.S.: Dr. R.M.L. Avadh University, Faizabad, India Ph.D.: Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, India POSTDOCTORAL TRAINING University of Pittsburgh Medical Center, Pittsburgh, PA Texas Tech University Health Sciences Center, Amarillo, TX Indiana University School of Medicine, Indianapolis, IN

Research Interest

RESEARCH INTERESTS: The long term research interests of his laboratory are: To investigate mechanisms of pro-oxidative stressors including ultraviolet B (UVB) and cigarette smoke generated oxidized lipids with platelet-activating factor (PAF) agonists activity in the modulation of cancer growth and metastasis, primarily melanoma and lung carcinoma. To determine mechanisms of tumor immune responses triggered by PAF-agonists in the effectiveness of melanoma and lung cancer therapies including immunotherapy. To evaluate effects of potentially applicable pharmacological and combination approaches including PAF-R antagonists to enhance the efficacy of melanoma therapies. They explore several cellular and molecular biology techniques including cell proliferation, survival and migration assays, gene deletion and overexpression, PCR, real time RT-PCR, ELISA, western blotting, and flow cytometry. In addition, we utilize various in vitro cell culture systems, in vivo mouse models of various strains including knockouts and transgenics as well as human samples in our research.

Publications

  • Sahu RP, Ocana JA, Harrison KA, Touloukian CE, Al-Hassani M, Sun L, Loesch M, Murphy RC, Althouse SK, Perkins SM, Speicher PJ, Tyler DS, Konger RL, Travers JB. Chemotherapeutic agents subvert tumor immunity by generating agonists of platelet-activating factor. Cancer Research. 2014; 74(23):7069-78.

  • Thyagarajan A, Sahu RP*. Potential contributions of antioxidants to cancer therapy: Immunomodulation and Radiosensitization. Integrative Cancer Therapy. 2017. doi: 10.1177/1534735416681659.

  • Thyagarajan A, Saylae J, Sahu RP*. Acetylsalicylic acid inhibits the growth of melanoma tumors via SOX2-dependent-PAF-R-independent signaling pathways. Oncotarget. 2017, 8(30):49959-49972.

Global Experts from United States of America

Global Experts in Subject

Share This Profile
Recent Expert Updates
  • Matthew L Stone
    Matthew L Stone
    pediatrics
    University of Virginia Health System; Charlottesville, VA
    United States of America
  • Dr.   Matthew
    Dr. Matthew
    pediatrics
    University of Virginia Health System; Charlottesville, VA
    United States of America
  • Dr.  L Stone Matthew
    Dr. L Stone Matthew
    pediatrics
    University of Virginia Health System; Charlottesville, VA
    United States of America
  • Dr.  L Stone
    Dr. L Stone
    pediatrics
    University of Virginia Health System; Charlottesville, VA
    United States of America
  • Dr. Matthew L Stone
    Dr. Matthew L Stone
    pediatrics
    University of Virginia Health System; Charlottesville, VA
    United States of America
  • Dr.  R Sameh
    Dr. R Sameh
    pediatrics
    King Abdul Aziz University
    United Arab Emirates
  • Dr.   R Ismail,
    Dr. R Ismail,
    pediatrics
    King Abdul Aziz University
    United Arab Emirates
  • Sameh R Ismail,
    Sameh R Ismail,
    pediatrics
    King Abdul Aziz University
    United Arab Emirates
  • Dr.   Sameh R Ismail,
    Dr. Sameh R Ismail,
    pediatrics
    King Abdul Aziz University
    United Arab Emirates
  • Dr.   William
    Dr. William
    pediatrics
    Maimonides Medical Center
    United States of America